Skip to main content
Screener/Healthcare/Biotechnology

PTCT — PTC Therapeutics, Inc.

NASDAQ
$82.08+1.03 (+1.28%)
Mid CapHealthcareHigh ROELow BetaLow P/E
$43.17
$87.50
$80.30
$83.05
EPS (TTM)$-2.33
P/E Ratio8.58
Dividend Yield—
Market Cap$6.51B
Volume1.72M
Prev Close$80.96
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$272.6M-$2.8M$-0.030.0%-1.0%
Q4 '25$164.7M-$135.0M$-1.6790.1%-82.0%
Q3 '25$211.0M$15.9M$0.2045.1%7.5%
Q2 '25$178.9M-$64.8M$-0.8393.6%-36.3%
Q1 '25$1.2B$866.6M$10.0498.9%73.7%
Q4 '24$213.2M-$65.9M$-0.8592.4%-30.9%
Q3 '24$196.8M-$106.7M$-1.3994.5%-54.2%
Q2 '24$186.7M-$99.2M$-1.2991.7%-53.1%
Get Your Daily Market Recap